Found 55 results
Filters: Keyword is Predictive Value of Tests  [Clear All Filters]
2011
Chawla S, Kim S, Loevner LA, Hwang W-T, Weinstein G, Chalian A, Quon H, Poptani H.  2011.  Prediction of disease-free survival in patients with squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.. AJNR Am J Neuroradiol. 32(4):778-84.
2010
Kim S, Loevner LA, Quon H, Kilger A, Sherman E, Weinstein G, Chalian A, Poptani H.  2010.  Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.. AJNR Am J Neuroradiol. 31(2):262-8.
Apostolova LG, Mosconi L, Thompson PM, Green AE, Hwang KS, Ramirez A, Mistur R, Tsui WH, de Leon MJ.  2010.  Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal.. Neurobiol Aging. 31(7):1077-88.
Maruta J, Suh M, Niogi SN, Mukherjee P, Ghajar J.  2010.  Visual tracking synchronization as a metric for concussion screening.. J Head Trauma Rehabil. 25(4):293-305.
2009
Weinsaft JW, Kim RJ, Ross M, Krauser D, Manoushagian S, LaBounty TM, Cham MD, Min JK, Healy K, Wang Y et al..  2009.  Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus.. JACC Cardiovasc Imaging. 2(8):969-79.
Brys M, Pirraglia E, Rich K, Rolstad S, Mosconi L, Switalski R, Glodzik-Sobanska L, de Santi S, Zinkowski R, Mehta P et al..  2009.  Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment.. Neurobiol Aging. 30(5):682-90.
Kamer AR, Craig RG, Pirraglia E, Dasanayake AP, Norman RG, Boylan RJ, Nehorayoff A, Glodzik L, Brys M, de Leon MJ.  2009.  TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects.. J Neuroimmunol. 216(1-2):92-7.
2008
Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, de Leon MJ, Doty RL, Stern Y, Pelton GH.  2008.  Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease.. Biol Psychiatry. 64(10):871-9.
Janik M, Cham MD, Ross MI, Wang Y, Codella N, Min JK, Prince MR, Manoushagian S, Okin PM, Devereux RB et al..  2008.  Effects of papillary muscles and trabeculae on left ventricular quantification: increased impact of methodological variability in patients with left ventricular hypertrophy.. J Hypertens. 26(8):1677-85.
de Santi S, Pirraglia E, Barr W, Babb J, Williams S, Rogers K, Glodzik L, Brys M, Mosconi L, Reisberg B et al..  2008.  Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline.. Neuropsychology. 22(4):469-84.
2007
Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, Rusinek H, Pelton GH, Honig LS, Mayeux R et al..  2007.  Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.. Neurology. 68(11):828-36.
Wegiel J, Kuchna I, Nowicki K, Frackowiak J, Mazur-Kolecka B, Imaki H, Wegiel J, Mehta PD, Silverman WP, Reisberg B et al..  2007.  Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration.. Acta Neuropathol. 113(4):389-402.
de Leon MJ, Mosconi L, Li J, De Santi S, Yao Y, Tsui WH, Pirraglia E, Rich K, Javier E, Brys M et al..  2007.  Longitudinal CSF isoprostane and MRI atrophy in the progression to AD.. J Neurol. 254(12):1666-75.
2005
Mosconi L, Tsui W-H, De Santi S, Li J, Rusinek H, Convit A, Li Y, Boppana M, de Leon MJ.  2005.  Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.. Neurology. 64(11):1860-7.
Glodzik-Sobanska L, Rusinek H, Mosconi L, Li Y, Zhan J, de Santi S, Convit A, Rich K, Brys M, de Leon MJ.  2005.  The role of quantitative structural imaging in the early diagnosis of Alzheimer's disease.. Neuroimaging Clin N Am. 15(4):803-26,x.
2004
Kaufmann P, Shungu DC, Sano MC, Jhung S, Engelstad K, Mitsis E, Mao X, Shanske S, Hirano M, DiMauro S et al..  2004.  Cerebral lactic acidosis correlates with neurological impairment in MELAS.. Neurology. 62(8):1297-302.
Mosconi L, de Santi S, Rusinek H, Convit A, de Leon MJ.  2004.  Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.. Expert Rev Neurother. 4(5):831-49.
Kaufmann P, Pullman SL, Shungu DC, Chan S, Hays AP, Del Bene ML, Dover MA, Vukic M, Rowland LP, Mitsumoto H.  2004.  Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS).. Neurology. 62(10):1753-7.
Pucar D, Koutcher JA, Shah A, Dyke JP, Schwartz L, Thaler H, Kurhanewicz J, Scardino PT, W Kelly K, Hricak H et al..  2004.  Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse.. Clin Prostate Cancer. 3(3):174-81.
Bulsara KR, Zomorodi AR, Enterline DS, George TM.  2004.  The value of magnetic resonance imaging in the evaluation of fatty filum terminale.. Neurosurgery. 54(2):375-9;discussion379-80.
2003
Morris EA, Liberman L, Ballon DJ, Robson M, Abramson AF, Heerdt A, D Dershaw D.  2003.  MRI of occult breast carcinoma in a high-risk population.. AJR Am J Roentgenol. 181(3):619-26.
2002
Liberman L, Morris EA, Lee MJoo-Young, Kaplan JB, LaTrenta LR, Menell JH, Abramson AF, Dashnaw SM, Ballon DJ, D Dershaw D.  2002.  Breast lesions detected on MR imaging: features and positive predictive value.. AJR Am J Roentgenol. 179(1):171-8.
Johnston DCC, Eastwood JD, Nguyen T, Goldstein LB.  2002.  Contrast-enhanced magnetic resonance angiography of carotid arteries: utility in routine clinical practice.. Stroke. 33(12):2834-8.
Morris EA, Liberman L, D Dershaw D, Kaplan JB, LaTrenta LR, Abramson AF, Ballon DJ.  2002.  Preoperative MR imaging-guided needle localization of breast lesions.. AJR Am J Roentgenol. 178(5):1211-20.
2001
De Santi S, de Leon MJ, Rusinek H, Convit A, Tarshish CY, Roche A, Tsui WH, Kandil E, Boppana M, Daisley K et al..  2001.  Hippocampal formation glucose metabolism and volume losses in MCI and AD.. Neurobiol Aging. 22(4):529-39.